PVRL2基因在胶质瘤中的表达及其与临床和免疫特征的相关性分析
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金(81360319);云南省2019年中药饮片产业发展专项资金(2019-YG-067)


Expression of PVRL2 gene in gliomas and its correlation with clinical and immunologic features
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探究脊髓灰质炎病毒受体相关蛋白2(PVRL2)基因表达与胶质瘤的预后、免疫浸润 和分子特征的关系。方法 利用UCSC 数据集分析PVRL2 基因表达差异,整合癌症基因组图谱(TCGA) 数据库中656 例胶质瘤(GBMLGG)患者的基因组和临床数据,研究PVRL2 表达与临床分级的关系。通 过R 包maxstat 确定最佳截断值,将样本分为高、低表达组,使用Kaplan-Meier 生存曲线和log-rank 检验 评估生存差异并进行Cox单因素回归分析。采用Pearson相关性分析PVRL2表达与肿瘤干性评分的相关 性。分析共表达基因、基因本体(GO)功能和京都基因与基因组数据库(KEGG)通路富集,构建PPI网络。 分析PVRL2 与免疫细胞浸润及免疫调节基因的相关性。结果 PVRL2 在25 种肿瘤中上调,5 种肿瘤中 下调,GBMLGG 中显著上调(P < 0.05)。PVRL2 在高级别胶质瘤的表达值(4.78±0.72)高于低级别胶质 瘤(4.41±0.51)(P< 0.001)。计算出最佳截断值为5.190 7,根据截断值将患者分成高、低表达组,Kaplan- Meier 生存分析显示在总胶质瘤患者及低级别、高级别胶质瘤患者中高表达组生存期均短于低表达组, 风险比均大于1,PVRL2 表达与死亡风险和疾病进展呈正相关(P < 0.05)。PVRL2 与基于DNA 甲基化、 差异甲基化、表观遗传学调控的DNA甲基化和增强子的DNA甲基化的干性评分呈正相关(均P< 0.001)。 PVRL2 与20 118 个基因共表达,富集分析显示其与细胞外基质、病毒感染、免疫调控、血管生成等功能 和通路相关,且与免疫调节性分子高度相关(FDR < 0.05)。PVRL2 表达与多种免疫细胞浸润和多数免 疫调节基因相关(P< 0.05)。结论 PVRL2 高表达与胶质瘤临床分级和预后不良相关,并与免疫调节密 切相关。

    Abstract:

    Objective To explore the relationship between poliovirus receptor-related protein 2 (PVRL2) gene expression and prognosis, immune infiltration, and molecular characteristics of gliomas. Methods University of California Santa Cruz( UCSC) dataset was used to analyze the differences in PVRL2 gene expression, and the genomic and clinical data of 656 glioma( GBMLGG) patients from The Cancer Genome Atlas( TCGA) database were integrated to study the relationship between PVRL2 expression and clinical grade. The optimal cutoff value was determined by R package maxstat, and the samples were divided into high- expression group and low-expression group, and survival differences were assessed using Kaplan- Meier survival curves and log-rank tests and analyzed by Cox one-way regression. The correlation between PVRL2 expression and tumor stemness score was analyzed using Pearson correlation. Co-expressed genes, gene ontology( GO)function and Kyoto encyclopedia of genes and genomes( KEGG) pathway enrichment were analyzed to construct PPI networks. Correlation with immune cell infiltration and immunomodulatory genes was analyzed. Results PVRL2 was up-regulated in 25 types of tumors, down-regulated in 5 types of tumors, and significantly up-regulated in GBMLGG, with statistically significant differences( P <0.05). The expression value of PVRL2 was higher in high-grade gliomas( 4.78±0.72) than in low-grade gliomas (4.41±0.51), and the difference was statistically significant( P < 0.001). The optimal cutoff value was calculated to be 5.190 7, and the patients were divided into high and low expression groups according to the cutoff value. Kaplan-Meier survival analysis showed that the survival of high expression group was shorter than that of low expression group in patients with total gliomas, low-grade, and high-grade gliomas, and the hazard ratios were all greater than 1, and that the PVRL2 expression was positively correlated with the risk of death and disease progression, and the differences were all statistical( P < 0.05). PVRL2 was positively correlated with stemness scores based on DNA methylation, differential methylation, epigenetic regulation of DNA methylation and enhancer DNA methylation, with statistically significant differences( all P < 0.001). PVRL2 was co-expressed with 20 118 genes, and enrichment analysis showed that it was associated with extracellular matrix, viral infection, immune regulation, angiogenesis, and other functions and pathways, and was highly correlated with immunomodulatory molecules( FDR<0.05). PVRL2 expression was associated with multiple immune cell infiltrates and most immunomodulatory genes with a statistical difference( P<0.05). Conclusions High PVRL2 expression correlates with clinical grade and poor prognosis of gliomas and is strongly associated with immune regulation.

    参考文献
    相似文献
    引证文献
引用本文

杨坤,白丽.PVRL2基因在胶质瘤中的表达及其与临床和免疫特征的相关性分析[J].神经疾病与精神卫生,2025,25(6):416-425
DOI :10.3969/j. issn.1009-6574.2025.06.006.

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-06-24